Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class IIOngoingZ-0921-2025

Device recall · January 22, 2025

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361 recall

Why: The user of the assay may either face a failure message during re-calibration of the Hybrid.XL instrument using the re-calibration R1 and R2 of the device or find controls out of specification (failed Control High) which causes a delay in results.

Class II: could cause temporary or reversible health problems; serious harm is remote.

The recall

Product

DRG:HYBRiD-XL Insulin. Model/Catalog Number: HYE-5361

Lots / codes

UDI: (01)04048474053616(17)20251130(10)429K084-1. Lot Number: 429K084-1

Quantity
10 units
Company
DRG International, Inc., Springfield, NJ
Distribution
Worldwide - US Nationwide distribution in the state of New Jersey and the countries of Czechia and Romania.
Initiated
October 7, 2024 · Voluntary: Firm initiated
Classified
January 15, 2025
Reported
January 22, 2025
How notified
Letter

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.